318
Participants
Start Date
June 30, 1999
Primary Completion Date
February 28, 2005
Study Completion Date
March 31, 2008
Temozolomide
200 mg/m2 body surface on days 1-5 every 28 days for 8 cycles; and again for another 4 cycles at primary progression
Focal radiotherapy
54-60 Gy in 28-30 fractions over 6-7 weeks
University of Heidelberg, Heidelberg
Neurology and Radiotherapy, Tübingen
Klinikum Aschaffenburg, Aschaffenburg
Nervenklinik, Bamberg
Charite, Berlin
Neurosurgery, Düsseldorf
Radiotherapy, Erlangen
Neurology, Essen
Neurosurgery, Frankfurt
Neurosurgery, Kiel
Neurosurgery, Mainz
County District Hospital, Regensburg
University Hospital Tuebingen
OTHER
Heinrich-Heine University, Duesseldorf
OTHER
Heidelberg University
OTHER
Charite University, Berlin, Germany
OTHER
University Hospital, Essen
OTHER
University of Leipzig
OTHER
University Hospital, Bonn
OTHER
German Cancer Research Center
OTHER
University of Zurich
OTHER
Neuro-Oncology Working Group of the German Cancer Society
NETWORK